Composite Biomarkers of Circulating MicroRNAs and Urine Metabolites in Early-Stage NSCLC

Authors

• Zarmina Alam
• Eric Bedard
• Sunita Ghosh, Henry Ford HealthFollow
• Aswin Abraham
• Faisal Habbab
• Wilson Roa

Recommended Citation

Alam Z, Bedard E, Ghosh S, Abraham A, Habbab F, Roa W. Composite Biomarkers of Circulating MicroRNAs and Urine Metabolites in Early-Stage NSCLC. J Thorac Oncol 2026; 21(5):1.

Document Type

Conference Proceeding

Publication Date

5-7-2026

Publication Title

J Thorac Oncol

Keywords

Oncology, Respiratory System

Abstract

Lung cancer continues to have the highest incidence and mortality rates globally. Early detection and monitoring of treatment response are key strategies to improve patient outcomes. Circulating microRNAs and urine metabolites have significant potential as non-invasive biomarkers to enhance lung cancer detection, monitor therapeutic response, and predict recurrence.

Volume

21

Issue

5

First Page

1